Business description
Bio-Gate is a medical technology company that employs unique silver technology to endow materials and products with antimicrobial properties. The focus of the product portfolio is medical technology products. Bio-Gate technology is based on the antimicrobial activity of silver ions. The company employs only pure metallic silver. Bio-Gate uses two different technologies. In the first, silver particles are incorporated into cosmetics, paints, veneers or plastics. The second involves coating final products - such as implants or wound dressings - with a silver-containing functional layer. Both technologies use extremely small particles of silver, to ensure that as many silver ions as possible are released.
Management board & Supervisory board
| CEO |
| Marc Lloret-Grau |
| Management board |
| Thomas Konradt |
| Supervisory board |
| Karl Richter, Volker Rofalski, Prof. Dr. Dr. Volker Alt |
Company data
| Name: |
Bio-Gate AG |
| Address: |
Neumeyerstraße 28-34,D-90411 Nürnberg |
| Phone: |
+49-911-4775-23–100 |
| Fax: |
+49-911-4775-23–101 |
| E-mail: |
info@bio-gate.de
|
| Internet: |
www.bio-gate.de/ |
| Industry: |
Healthcare |
| Sector: |
Medical Products |
| Sub sector: |
Advanced Medical Devices |
| End of financial year: |
12/31 |
| Free Float: |
18.30% |
| IPO date: |
4/5/2006 |
Investor relations
| Name: |
Gerd Rückel |
| IR phone: |
+49-6172-807-309 |
| IR Fax: |
- |
| IR e-mail: |
presse@bio-gate.de
|
